Physician

Sarah Kassaby, M.D.

According to 2025 Medicare claims, Sarah Kassaby, M.D. (NPI: 1922428689) practices pathology in the Kingsport-Bristol, TN-VA market, with the plurality of this provider's patient population coming from Sullivan, TN. This provider's primary affiliated billing organization is OUTPATIENT CYTOPATHOLOGY CENTER (NPI: 1275740987; TIN: 621634273) and primary practice location at 37601-1111.

Kassaby's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 276 traditional Medicare patients, billed 2,554 HCPCS/CPT codes, and received $170,375 in Medicare payments. The top billing code was 88173 (Evaluation of fine needle aspirate with interpretation and report). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $555 to $170,375. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	14	20	$555
2021	293	1,584	$116,438
2022	333	2,150	$147,646
2023	295	2,208	$150,268
2024	276	2,554	$170,375

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

No connected Part D records

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
88173	Evaluation of fine needle aspirate with interpretation and report	232	496	$121
10005	Fine needle aspiration biopsy using ultrasound guidance, first growth	231	238	$95
76982	Ultrasound scan of growth for measuring elasticity, first growth	220	226	$67
76983	Ultrasound scan of growth for measuring elasticity, each additional growth	200	311	$44
88172	Evaluation of fine needle aspirate	232	497	$41

Top 5 Part D drugs in 2024

By total drug costs.

No connected Part D drug-level records for 2024.

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Sarah Kassaby, M.D.?

Tedicare shows public-source Medicare data for Sarah Kassaby, M.D. (NPI 1922428689), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sarah Kassaby, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sarah Kassaby, M.D.?

Sarah Kassaby, M.D. is linked to OUTPATIENT CYTOPATHOLOGY CENTER (billing NPI 1275740987) in the available physician profile data.

Does Sarah Kassaby, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.